PRTA Prothena Corporation plc
$8.93▼ -1.00%
Healthcare
Other
After hours
$8.93▲ +0.00%
Sep 11, 7:30 PM ET
Volume 376.3K
Avg Volume (10D) 335.1K
Key Metrics & Fundamentals
Market Cap
$458.44M
P/E Ratio
–
Div Yield
–%
52W Range
7.73 - 11.80
% vs 50 MA
-1.00%
% vs 200 MA
-5.70%
RSI-14
44.1
MACD Histogram
-0.0600
Beta (1Y vs SPY)
1.02
Free Cash Flow
-$25.70M
Gross Rev
$1.01M
Gross Profit
$1.01M
EBITDA
-$16.08M
COGS
–
Operating Exp
$19.70M
Operating Income
-$18.69M
EBIT
-$18.69M
Pretax Income
-$18.58M
Net Income
-$18.58M
EPS (Diluted)
-0.36
Price & Volume History
Loading chart…
Recent News
Prothena to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Wire · Sep 9, 2026 8:05 PM
Real Parkinson’s Disease Hope from Jupiter Neurosciences
Exec Edge · Aug 19, 2026 4:32 PM
KMDA or PRTA: Which Is the Better Value Stock Right Now?
Zacks · Aug 14, 2026 3:40 PM
PRTA's Q2 Loss Narrower Than Expected, Pipeline Progress in Focus
Zacks · Aug 7, 2026 5:41 PM
Prothena (PRTA) Reports Q2 Loss, Misses Revenue Estimates
Zacks · Aug 6, 2026 11:10 PM
Prothena: Q2 Earnings Snapshot
Associated Press · Aug 6, 2026 9:22 PM
Prothena Reports Second Quarter 2026 Financial Results and Business Highlights
Business Wire · Aug 6, 2026 8:05 PM
Vanda Pharmaceuticals (VNDA) Reports Q2 Loss, Lags Revenue Estimates
Zacks · Aug 5, 2026 9:10 PM
Prothena to Report Second Quarter 2026 Financial Results on August 6
Business Wire · Jul 30, 2026 8:05 PM
PRTA Stock Rises Nearly 11% in Six Months: What's Driving It?
Zacks · Jul 9, 2026 3:38 PM
Financial Overview - Income Statement
Quarterly
Jun 2026
See PRTA's money flow as a full page
Social Sentiment
No Reddit posts found for PRTA.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.